Bolt Biotherapeutics (BOLT) traded up 49.64 % during a 24 hours period ending at 08:01 PM Central Europe on Monday 26th. One Bolt Biotherapeutics stock can currently be bought for about USD 6.56 on popular exchanges. Current supply of Bolt Biotherapeutics stocks is 1.9 mn. Bolt Biotherapeutics has a current market capitalization of USD 12.1 mn and approximately USD 80.2 mn worth of Bolt Biotherapeutics was traded on exchanges in the last 24 hours. Since last month end, Bolt Biotherapeutics has traded 74.65 % up. Simple moving average of last 200 days is at USD 4.5. The highest price of past 52 weeks was recorded at USD 7.78 on 10/23/2026. 52 weeks low was at USD 3.1 on 09/18/2026.
Here is how related stocks have performed in the past 24 hours:
Greenlight Metals (GRLMF) traded up 7.57 % and now trades at USD 0.16. Current market capitalisation for Greenlight Metals is USD 14.3 mn.
Firefly Neuroscience (AIFF) traded down -9.8 % and now trades at USD 0.95. Current market capitalisation for Firefly Neuroscience is USD 14.4 mn.
Tmd Energy (TMDE) traded up 7.56 % and now trades at USD 0.58. Current market capitalisation for Tmd Energy is USD 14.4 mn.
Tomi Environmental (TOMZ) traded up 1.39 % and now trades at USD 1.43. Current market capitalisation for Tomi Environmental is USD 14.3 mn.
Fractyl Health (GUTS) traded down -4.42 % and now trades at USD 1.06. Current market capitalisation for Fractyl Health is USD 14.3 mn.
About Bolt Biotherapeutics
Bolt Biotherapeutics, Inc. is a biotechnology company operating in the health care sector with its base in Redwood City, United States. These immune-stimulating antibody conjugates they develop are a new class of cancer therapeutics. Systemically-administered, they uncover the immune system to induce anti-tumor immunity. Bolt Biotherapeutics serves the healthcare industry in the United States. You can find more information about their work on their website, www.boltbio.com , and they are Nasdaq-listed.
